Drug Trials Snapshots: LIVDELZI

Drug Trials Snapshots: LIVDELZI

Summary

LIVDELZI is a peroxisome proliferator-activated receptor (PPAR)-delta agonist that is used to treat primary biliary cholangitis (PBC) in combination with ursode...

Description

LIVDELZI is a peroxisome proliferator-activated receptor (PPAR)-delta agonist that is used to treat primary biliary cholangitis (PBC) in combination with ursode...

Original reporting

AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.

Open original source

Related coverage